patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · protein
aflibercept biosimilar
Marketedupdated 2mo agoby Sam Chun Dang Pharm Co Ltd🔗 ChEMBL
Approvedcommunity read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with 16 approved and 39 investigational indications.
indications
investigational
Diabetic Macular Edema
targets
Placenta growth factorVascular endothelial growth factor A, long form
all catalysts(3)
approval · 3
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that